3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
5
Pancreatic Cystic Neoplasm
1
Gastrointestinal Stromal Tumor of Stomach
1
Esophageal Neoplasms
1
Cholangitis, Sclerosing
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
22
Cisplatin
17
durvalumab
12
lenvatinib
11
Oxaliplatin
11
pembrolizumab
6
Liver Transplantation
4
Leucovorin
4
Floxuridine
4
tislelizumab
3
Taxes
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Folfox protocol
3
Fluorouracil
3
Drug Therapy
3
Capecitabine
3
Biopsy
3
Albumin-Bound Paclitaxel
3
tremelimumab
2
pemigatinib
2
olaparib
2
ivosidenib
2
irinotecan sucrosofate
2
apatinib
2
Specimen Handling
2
Injections
2
Immunoglobulin G
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Cholangiocarcinoma
×
Endoscopic Ultrasound-Guided Fine Needle Aspiration
×
Clear all
NCT05187312
2024-04-12
ERDB
Region Stockholm
Recruiting
1,000 enrolled